Panakeia improves patient outcomes
by making biomarker profiling faster
and more accessible for informing
diagnosis, treatment and drug development
It all begins with patient experience
The story of Panakeia begins with a patient-centred approach to innovation and is driven by empathy. Co-founder & CEO, Pahini Pandya, experienced first hand the anxiety that patients and their families suffer when waiting for a cancer diagnosis. Her experience compelled a desire to translate a decade in the field of cancer research into solutions addressing these issues. She met co-founder & CTO Pandu Raharja-Liu via Entrepreneur First.
Pandu Raharja-Liu, an expert in building AI in cancer space, had also seen first-hand patient the delays and challenges in cancer diagnosis causing patient distress. Together they founded Panakeia with the vision of making precision medicine accessible for patients all over the world. Today, the team is leveraging strong, interdisciplinary expertise to develop solutions and together they are ushering in next generation of biomarker profiling.